VHL Syndrome Q&A with Roswell Park Comprehensive Cancer Center - Quiz - MDSpire

VHL Syndrome Q&A with Roswell Park Comprehensive Cancer Center

VHL (von Hippel-Lindau disease) is a rare genetic disease that can cause tumors, both benign and malignant, to develop in up to ten different organs throughout a patient's life.

  • January 30, 2023

Share

Original Source(s)

VHL Syndrome Q&A with Roswell Park Comprehensive Cancer Center

  • January 30, 2023

Related Content

Editorial: Overcoming resistance to immune checkpoint inhibitors: mechanisms and strategies in cancer therapy

Efficacy and Safety of Neoadjuvant Therapies for High-Risk and Locally Advanced Prostate Cancer in Older Adults: A Systematic Review and Network Meta-Analysis

Retrospective Characterization of Specialized Palliative Care in Patients With Gliomas

Patients with gliomas face significant challenges in daily life due to rapidly progressing neurological and cognitive symptoms. This study evaluated referral processes for specialized palliative care and interdisciplinary services used by patients with gliomas and their caregivers in Denmark.